Krystal Biotech, Inc. (KRYS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$251.78
Day's range
$260.56

Krystal Biotech Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 08/13/2026 4.42 M $1.64 B   1.01% 14.96%
BLACKROCK, INC. 08/07/2026 4.18 M $1.55 B   6.12% 14.16%
AVORO CAPITAL ADVISORS LLC 08/14/2026 2.89 M $1.07 B   0.00% 9.78%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 1.57 M $585.34 M   8.11% 5.33%
STATE STREET CORP 08/07/2026 1.35 M $502.20 M   2.79% 4.58%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 1.24 M $461.08 M   6.46% 4.20%
SOLEUS CAPITAL MANAGEMENT, L.P. 08/11/2026 939.25 K $349.09 M   -18.54% 3.18%
CAPITAL WORLD INVESTORS 08/12/2026 777.84 K $289.10 M   -5.68% 2.63%
VESTOR CAPITAL, LLC 07/28/2026 700.91 K $78.19 M   350,357.00% 2.37%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 698.99 K $259.84 M   8.54% 2.37%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 687.40 K $255.49 M   41.71% 2.33%
HOOD RIVER CAPITAL MANAGEMENT LLC 08/14/2026 663.38 K $246.56 M   7.07% 2.25%
REDMILE GROUP, LLC 08/14/2026 632.01 K $234.90 M   -6.16% 2.14%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 08/12/2026 570.15 K $211.91 M   40.03% 1.93%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 08/14/2026 481.31 K $178.89 M   0.00% 1.63%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 476.04 K $176.94 M   1.50% 1.61%
FIRST TRUST ADVISORS LP 08/11/2026 324.90 K $120.76 M   -7.31% 1.10%
INVESCO LTD. 08/14/2026 324.76 K $120.70 M   29.19% 1.10%
GOLDMAN SACHS GROUP INC 08/14/2026 298.84 K $111.07 M   39.03% 1.01%
NORTHERN TRUST CORP 08/13/2026 283.78 K $105.47 M   12.41% 0.96%
FRANKLIN RESOURCES INC 08/13/2026 261.92 K $97.35 M   46.11% 0.89%
NORGES BANK 08/12/2026 259.03 K $96.27 M   100.00% 0.88%
JUPITER TOPCO LLC 08/14/2026 256.67 K $95.39 M   100.00% 0.87%
BANK OF AMERICA CORP /DE/ 08/14/2026 256.43 K $95.31 M   -1.62% 0.87%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 254.83 K $94.71 M   5.31% 0.86%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 254.83 K $94.71 M   100.00% 0.86%
MORGAN STANLEY 08/13/2026 235.49 K $87.53 M   12.63% 0.80%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 189.53 K $70.44 M   5.79% 0.64%
PRINCIPAL FINANCIAL GROUP INC 08/04/2026 169.55 K $63.02 M   4.62% 0.57%
BANK OF NEW YORK MELLON CORP 08/06/2026 163.61 K $60.81 M   9.58% 0.55%
RAYMOND JAMES FINANCIAL INC 08/14/2026 158.68 K $58.97 M   1.67% 0.54%
WOODLINE PARTNERS LP 08/14/2026 150.62 K $55.98 M   0.00% 0.51%
UBS GROUP AG 08/13/2026 148.32 K $55.12 M   3.34% 0.50%
NUVEEN, LLC 08/11/2026 146.52 K $54.46 M   2.20% 0.50%
BRAIDWELL LP 08/14/2026 128.98 K $47.94 M   -29.30% 0.44%
VOYA INVESTMENT MANAGEMENT LLC 08/12/2026 124.44 K $46.25 M   14.80% 0.42%
TIMESSQUARE CAPITAL MANAGEMENT, LLC 08/07/2026 111.55 K $41.46 M   -0.71% 0.38%
PICTET ASSET MANAGEMENT HOLDING SA 07/30/2026 107.80 K $40.07 M   -2.59% 0.37%
PUBLIC SECTOR PENSION INVESTMENT BOARD 08/13/2026 105.52 K $39.22 M   14.33% 0.36%
1832 ASSET MANAGEMENT L.P. 08/13/2026 99.30 K $36.91 M   133.10% 0.34%
WESTFIELD CAPITAL MANAGEMENT CO LP 08/12/2026 98.71 K $36.69 M   100.00% 0.33%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 92.23 K $34.28 M   -0.86% 0.31%
HANDELSBANKEN FONDER AB 07/10/2026 90.41 K $33.60 M   -1.09% 0.31%
JPMORGAN CHASE & CO 08/12/2026 87.34 K $33.48 M   -11.87% 0.30%
NANTAHALA CAPITAL MANAGEMENT, LLC 08/19/2026 85.00 K $31.59 M   100.00% 0.29%
ORBIMED ADVISORS LLC 08/14/2026 83.20 K $30.92 M   20.41% 0.28%
CAPTION MANAGEMENT, LLC 08/14/2026 78.00 K $28.99 M   -54.12% 0.26%
S SQUARED TECHNOLOGY, LLC 08/14/2026 77.55 K $28.82 M   -10.06% 0.26%
BELLEVUE GROUP AG 08/14/2026 77.53 K $28.82 M   -83.91% 0.26%
BIONDO INVESTMENT ADVISORS, LLC 08/13/2026 70.95 K $26.37 M   -1.53% 0.24%

Krystal Biotech Inc institutional Ownership - FAQ's

During the previous two years, 513 institutional investors and hedge funds held shares of Krystal Biotech Inc. The most heavily invested institutionals were:

FMR LLC: 4.42 M

BlackRock, Inc.: 4.18 M

Avoro Capital Advisors LLC: 2.89 M

VANGUARD PORTFOLIO MANAGEMENT LLC: 1.57 M

STATE STREET CORP: 1.35 M

VANGUARD CAPITAL MANAGEMENT LLC: 1.24 M

103.48% of Krystal Biotech Inc stock is owned by institutional investors.

Institutional investors have bought a total of 39.58 M shares in the last 24 months. This purchase volume represents approximately $10.24 B in transactions.